Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of MLN8237 in Japanese Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma
jRCT2080221799Phase 1
- Sponsor
- Takeda
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of alisertib in non-Hodgkin lymphoma (NHL), sponsored by Takeda.
02
Drugs
alisertib
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on jRCT2080221799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221799.